Burning Rock Biotech Limited
BNR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $131,617 | $148,554 | $133,082 | $126,022 |
| % Growth | -11.4% | 11.6% | 5.6% | – |
| Cost of Goods Sold | $32,773 | $40,451 | $35,681 | $36,600 |
| Gross Profit | $98,844 | $108,103 | $97,401 | $89,422 |
| % Margin | 75.1% | 72.8% | 73.2% | 71% |
| R&D Expenses | $41,469 | $49,770 | $40,389 | $52,203 |
| G&A Expenses | $31,698 | $31,417 | $31,303 | $37,289 |
| SG&A Expenses | $73,506 | $69,830 | $72,191 | $84,019 |
| Sales & Mktg Exp. | $41,808 | $38,413 | $40,888 | $46,730 |
| Other Operating Expenses | $0 | $0 | $0 | $35,127 |
| Operating Expenses | $114,975 | $119,600 | $112,580 | $171,349 |
| Operating Income | -$16,131 | -$11,497 | -$15,179 | -$81,927 |
| % Margin | -12.3% | -7.7% | -11.4% | -65% |
| Other Income/Exp. Net | -$415 | $2,039 | $1,903 | $5,947 |
| Pre-Tax Income | -$16,546 | -$9,458 | -$13,276 | -$75,980 |
| Tax Expense | $212 | $244 | $224 | $5,314 |
| Net Income | -$16,758 | -$9,702 | -$13,500 | -$81,294 |
| % Margin | -12.7% | -6.5% | -10.1% | -64.5% |
| EPS | -15.6 | -9 | -12.5 | -78.7 |
| % Growth | -73.3% | 28% | 84.1% | – |
| EPS Diluted | -15.6 | -9 | -12.5 | -78.7 |
| Weighted Avg Shares Out | 1,077 | 1,077 | 1,076 | 1,034 |
| Weighted Avg Shares Out Dil | 1,077 | 1,077 | 1,076 | 1,034 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,729 | $2,226 | $2,581 | $1,814 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $12,847 | $12,847 | $0 | $0 |
| EBITDA | -$3,284 | $1,350 | -$15,179 | -$46,800 |
| % Margin | -2.5% | 0.9% | -11.4% | -37.1% |